Replies to post #264511 on NorthWest Biotherapeutics Inc (NWBO)

[X Master]

Really, how did you get that out of the conversation?

[sharpie510]

The company has made it clear they have access to more money from friendly investors if needed.

I like that UCLA received a grant to help fund the Keytruda DCVax-L combo trial. NWBO will benefit immensely if one or both of the cohorts shows efficacy (DCVax-L only or Keytruda + DCVax-L). Dr. Quiñones-Hinojosa stated on record 4 months ago that NWBO is working with the Mayo Clinic in SEVERAL clinical trials:

And the company is essentially worth $20B or more with a positive phase III DCVax-L trial with the potential value of DCVax-Direct in tow.

I believe we will know soon. This is why they are only raising money in small batches, and this is why they have not yet announced the ASM. I don't think they are dragging the date out only to tell us no news. If they planned to say nothing, they would've gotten the ASM done and over with as early as possible.

imho...

So no money, no more trials, the company is essentially worthless with a failed trial imho...

[sentiment_stocks]

Let’s wait for top line to see how worthless they are. In the meantime, I’ll completely, and respectfully, disagree with you.